Cynata Therapeutics Limited announced that it has received approval by the Central Adelaide Local Health Network Human Research Ethics Committee to commence a clinical trial of Cynata’s Cymerus™ MSC product in patients with diabetic foot ulcers.
[Cynata Therapeutics Limited (BioSpace)]